Taken together, these data suggest that targeting the enzymes that regulate ceramide formation and SphKs and application of antioxidants to improve a rheostat of ceramide-S1P would be new therapeutic strategies to prevent oxidative-stress-mediated kidney diseases. The gene discussed is MBTPS1; the disease is kidney disorder.